|
|||||
|
|
Impact of the COVID-19 pandemic on people living with migraine: Results of the MiCOAS qualitative study |
|
| Authors: | Dawn C. Buse PhD Maya T. Gerstein DrPH Carrie R. Houts PhD James S. McGinley PhD Alyssa A. Uzumcu BA Kelly P. McCarrier PhD Alexis Cooke PhD Nancy M. Touba MPH Tracy K. Nishida PhD R. J. Wirth PhD Richard B. Lipton MD |
| Affiliation: | 1. Vector Psychometric Group, LLC, Chapel Hill, North Carolina, USA;2. Patient Centered Outcomes, Open Health Group, Bethesda, Maryland, USA;3. Neurology, Albert Einstein College of Medicine, Bronx, New York, USA Headache, Montefiore Medical Center, Bronx, New York, USA |
| Abstract: | |
| Keywords: | coronavirus disease 2019 (COVID-19) Food and Drug Administration impact migraine pandemic qualitative |